Sitemap

November 04, 2008 Articles

Filter by Available Specialty
  1. Akorn reports $2.4 million in third-quarter income
  2. AMO voluntarily recalls single lot of Healon D OVD
  3. FDA approves bendamustine hydrochloride for NHL
  4. Insulin associated with greater glycemic control, beta-cell function than oral antidiabetes agents
  5. Nearly 95% of femoral neck fractures treated with ORIF healed without shortening
  6. New consensus statement on carotid intima-media thickness measurement
  7. Regeneron posts $21.1 million net loss for third quarter
  8. Researchers describe new hereditary erosive corneal disease
  9. Statin therapy may complicate prostate cancer detection
  10. Volume overload at the AAO